Explore how the expiration of ACA premium subsidies by 2025 may impact health insurance costs and the uninsured rate across the U.S. Act now to prepare!

Medicare Advantage OTC benefits provide seniors with vital health product allowances, but utilization is low due to awareness and complexity. Plan reductions and inflation heighten the importance of optimizing these benefits.

AMA's 2024 report reveals high concentration levels in U.S. commercial and Medicare Advantage health insurance markets, highlighting key insurers' dominant shares across metro areas.

The expiration of enhanced ACA premium tax credits threatens Iowa farmers with sharp insurance premium increases, impacting rural economies and health coverage options for 2026.

House Speaker Mike Johnson will not call a vote to renew enhanced ACA subsidies, leading to higher health insurance premiums in 2024 marketplace plans amid Republican opposition and budget negotiation challenges.

House Judiciary Committee investigates major Obamacare insurers and brokers over potential fraud inflating program costs, focusing on enrollment practices and subsidy misuse.

AM Best hosts expert panel to analyze Medicare Advantage challenges and market outlook amid rising costs and utilization trends in U.S. health insurance.

With the expiry of COVID-era ACA tax credits, millions face higher health insurance premiums and deductibles in 2026, impacting coverage affordability and market dynamics.

Congress faces a critical deadline as enhanced Affordable Care Act subsidies look set to expire amid political stalemate, threatening higher premiums for millions.

The AMA's 2024 study reveals high concentration levels in US commercial and Medicare Advantage health insurance markets, driven by mergers and acquisitions, impacting competition and consumer choices.